“Sustained Hair Regrowth With Ritlecitinib to Week 48 in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b 3 Study”. 2023. SKIN The Journal of Cutaneous Medicine 7 (2): s188. https://doi.org/10.25251/skin.7.supp.188.